Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health: Psychology

The Association of State and Provincial Psychology Boards (ASPPB) Selects Certemy for Exam Candidate Management and Score Reporting

Leave a comment


ASPPB logo

ASPPB logo

ASPPB will use Certemy to streamline and automate their examination process for psychology boards in all fifty states of the United States, the District of Columbia, the U.S. Virgin Islands, Puerto Rico, Guam, and all ten provinces of Canada.


COSTA MESA, Calif. (PRWEB)

Certemy, a leading provider of credentialing management software for certification and licensing organizations, announced today that the Association of State and Provincial Psychology Boards (ASPPB) has selected Certemy to streamline and automate their examination process for all member boards. ASPPB supports state, provincial, and territorial agencies responsible for the licensure of psychologists throughout the United States and Canada. Certemy will replace Pearson Credentialing Manager (PCM), a credentialing software platform that is being phased out by its parent company in 2020.

“Certemy provides all the functionality and customizability we need to replace PCM at a reasonable cost,” said Matthew Turner, Ph.D., Senior Director of Examination Services at the Association of State and Provincial Psychology Boards (ASPPB). “We are confident that Certemy’s product capabilities and industry expertise will ensure a robust and flexible solution for ourselves and our member boards.”

Certemy Benefits for ASPPB


  • One comprehensive solution that standardizes, streamlines, and automates the test registration, candidate tracking, and score reporting processes for all ASPPB jurisdictions (member boards) throughout North America and Canada

  • Seamless integration with Pearson VUE using Single Sign On (SSO) and automated, API-driven data exchange

  • Ability to create and change workflows without custom programming

  • Option to customize workflows for individual jurisdictions or regions

  • Simplified management of registration invalidations

  • Automated collection of online payments with immediate receipt of funds

  • Access to aggregated data for reporting, analysis, and decision support

  • Option to collect custom data to drive additional insights

Certemy Benefits for ASPPB Jurisdictions (Member Boards)

  • Fully automated, ASPPB-approved solution for test registration, candidate tracking, and score reporting

  • Automatic system-generated reminders to ensure candidates register and complete tests on time

  • Streamlined management of candidate test accommodations

About ASPPB

The Association of State and Provincial Psychology Boards (ASPPB) is the alliance of state, provincial, and territorial agencies responsible for the licensure and certification of psychologists throughout the United States and Canada. ASPPB was formed to serve psychology boards in the two countries. Currently, the psychology boards of all fifty states of the United States, the District of Columbia, the U.S. Virgin Islands, Puerto Rico, Guam and all ten provinces of Canada are members of ASPPB. Learn more about ASPPB at https://www.asppb.net.

About Certemy

Certemy is the most affordable and configurable SaaS software platform for professional credentialing and exam management. Our platform streamlines and automates credentialing and testing workflows to help credentialing organizations become more efficient, transparent, and agile while reducing IT costs and administrative burdens. We help our customers automate exam candidate management and score reporting by integrating with popular test delivery solutions. We deliver the lowest cost of ownership for any comparable solution with predictable SaaS pricing and no implementation or change fees. And we provide the only solution that business users can change themselves without IT help or programming. An active member of the credentialing community, Certemy is a proud member of The Council on Licensure, Enforcement and Regulation (CLEAR), the Institute for Credentialing Excellence (ICE), and the Association of Test Publishers (ATP). Learn more about Certemy at https://certemy.com.

Share article on social media or email:

Health

The Rubino OB/GYN Group’s Warren Office Moves Into A New Modern Space & Introduces A New NJ Top Doc

Leave a comment


Rhonda Sanderson, MD, FACOG

Rhonda Sanderson, MD, FACOG

We have moved into a wonderful, new office location where Dr. Sanderson can continue to provide experienced, expert care to women and mothers-to-be in the area.


SCOTCH PLAINS, N.J. (PRWEB)

NJ Top Docs practice, The Rubino OB/GYN Group hosted a ribbon-cutting ceremony for its new location at 27 Mountain Blvd. in Warren, NJ on Thursday, January 16 at 12PM. The Rubino OB/GYN Group founder, Dr. Robert Rubino, was joined by practice staff and local elected officials for the ribbon-cutting ceremony. Members of the public and media were also in attendance.

The office space at 27 Mountain Boulevard, Suite 6 in Warren marks The Rubino OB/GYN Group’s sixth space in New Jersey, joining offices in Bayonne, Clark, Madison, Summit and West Orange. The Warren office is home to new doctors including reviewed and approved NJ Top Doc, Dr. Rhonda Sanderson who began seeing patients in Warren this month. Other physicians in the group will see patients in Warren in the near future.

“This is an exciting time for our Warren, NJ practice,” explains Dr. Rubino. “We have moved into a wonderful, new office location where Dr. Sanderson can continue to provide experienced, expert care to women and mothers-to-be in the area. As ROG continues to grow, we are able to elevate our standards for women’s health care for the benefit of our patients.”

Dr. Sanderson joined The Rubino OB/GYN Group in summer 2019 and has an established presence in Warren. She has a particular interest in perimenopausal disorders, osteoporosis, sexual dysfunction, and abdominal pain. She will see patients on Mondays and Tuesdays from 8:30AM until 5PM and on Thursdays from 8:30AM until 6PM.

Dr. Sanderson completed her residency at Women and Infants’ Hospital of Brown University and received a medical degree from Drexel Medical School. Dr. Sanderson is a member of the Union County Medical Society, the New Jersey Medical Society, and the American College of Obstetrics and Gynecology. She has been listed as a “Best Doctors in New York” in New York Magazine and has been recognized as a Castle Connelly “Best Doctor” since 2004.

The Rubino OB/GYN Group offers sophisticated, non-invasive solutions to women’s healthcare in a welcoming and patient-centered environment. Mammograms are available to all women, not just patients. To schedule an appointment with a doctor, please call The Rubino OB/GYN Group office at 973-736-1100 or visit https://rubinoobgyn.com/mammograph/.

To view our new video series, “Ask Your Doctors,” which address mammograms and other healthcare topics, please follow us on Facebook at @TheRubinoOBGYNGroup or on YouTube at The Rubino OBGYN Group.

To learn more about the NJ Top Docs approved providers at The Rubino OB/GYN Group, please click here: https://njtopdocs.com/nj-doctors/rubinoobgyn/

Share article on social media or email:

Industry: Healthcare

The Team Type 1 Foundation Announces Partnership with VeloCity Cycling event supports Grady Health System

Leave a comment


The third annual VeloCity event takes place on May 2nd and begins on the Mercedes-Benz Stadium field

“The Team Type 1 Foundation is honored to officially partner with such a beloved institution in Atlanta. Our alliance with VeloCity and the Grady Health Foundation allows us to continue increasing public awareness of diabetes,” Team Type 1 Foundation Founder and President Phil Southerland said.


ATLANTA (PRWEB)

The Team Type 1 Foundation, a nonprofit organization pursuing a global mission of education, empowerment, and equal access to medicine for everyone affected by diabetes, announced a partnership with VeloCity, a fundraising ride benefiting Grady Hospital, around the shared goals of wellness and cycling.

The third annual VeloCity event takes place on May 2nd and begins on the Mercedes-Benz Stadium field and ends at the Home Depot Backyard. The event, designed for cyclists of all experience levels, features four full-supported routes ranging from a 62-100 mile pro ride, a 20-mile beginner option, and a seven-mile kids ride. Additionally, there will be indoor cycling classes taking place at the Home Depot Backyard. In 2019, more than 1,330 riders participated in the event, which is the only cycling event based in downtown Atlanta.

“The Team Type 1 Foundation is honored to officially partner with such a beloved institution in the Atlanta area. Our alliance with VeloCity and the Grady Health Foundation allows us to continue increasing public awareness of diabetes and showing what’s possible with the condition,” Team Type 1 Foundation Founder and President Phil Southerland said. “Frequently people with type 1 diabetes are told they cannot participate in sports. The Team Type 1 Foundation works to change the perception of diabetes and sports, and together with VeloCity, we are eager to empower people to get out and ride.”

“There are few things more important than the overall health of our community. VeloCity was created three years ago to help fund the care that Grady provides to thousands of patients every year and to create an opportunity to bring our city together in a way that celebrates wellness,” Grady Health Foundation President Joselyn Baker added. “We could not be more excited about this partnership with Team Type 1 and look forward not only to cheering on their team this May but to working together to grow this into one of Atlanta’s marquis sporting events.”

There is much more to the VeloCity event than just riding. It kicks off with a group pre-ride breakfast and concludes with a post-ride celebration with lunch, drinks, music and amenities such as a shower trailer, massage tent and activities for kids.

Medalist Sports, who are known for putting on large scale cycling events like the Tour of California, handle the management of the event. All rides are fully supported with rest stops every 10 miles, support vehicles, and a rider tracking system.

The Team Type 1 Foundation has pledged to raise more than $100,000 around the event. As part of its fundraising efforts, the Team Type 1 Foundation will bring riders from the Team Novo Nordisk development team, all who race with type 1 diabetes.

To register:

To support the Team Type 1 Foundation for this year’s VeloCity event, please visit http://give.gradyhealthfoundation.org/goto/TeamType1 and register.

All participants receive a t-shirt and SWAG bag. Funds raised by the event support Grady’s comprehensive, lifesaving trauma and emergency services, which are used by over 150,000 patients every year (400+ visits/day).

ABOUT TEAM TYPE 1 FOUNDATION

Established in 2005, the Team Type 1 Foundation is a nonprofit organization pursuing a mission of showing the world that with proper health, exercise and equal access to medicine, anyone with diabetes can achieve their dreams. As the world’s largest diabetes and sports organization we strive to dispel the stigma that people with diabetes can’t. WE CAN! WE DO! We are What’s Possible!!

For more information about Team Type 1 visit http://www.teamtype1.org.

Media Contact:

Nora McCulloch

nora.mcculloch@teamtype1.org

Share article on social media or email:

Health

NeoTract Designates Dr. Biren Patel as UroLift® Center of Excellence

Leave a comment


News Image

“We are pleased to recognize Dr. Biren Patel as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson


PLEASANTON, Calif. (PRWEB)

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Biren Patel, MD, in Arizona Advanced Urology PLLC, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Patel has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are pleased to recognize Dr. Biren Patel as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “This achievement has helped many patients experience durable, longterm relief from the burdensome symptoms of BPH while preserving sexual function*1,2.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.Teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

###

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Industry: Healthcare

Georgetown Home Care Announces Lowest Readmission and Rehospitalization Rate in Company History for 2019

Leave a comment



WASHINGTON (PRWEB)

Today, Georgetown Home Care (GHC) announces its 2019 hospital readmission rate and skilled nursing facility rehospitalization rate are the lowest in the company’s history.

Georgetown Home Care’s hospital readmission rate for 2019 was 4.7 percent, a 29 percent drop year over year. GHC’s skilled nursing facility (SNF) rehospitalization rate was 0 percent in 2019. When compared to the US national averages, these results are remarkable. The US national readmission rate for hospitals in 2019 was 14.7 percent, the US national skilled nursing facility rehospitalization rate was 22.3. Overall Georgetown Home Care has seen a significant decrease in the readmission rate with every partner hospital and SNF it works with, contributing to the great success GHC saw last year; and continues to build on in 2020.

“We work very closely with our partner hospitals and skilled nursing facilities to create good transitions of care from facility to home, said John Bradshaw, CEO of Georgetown Home Care. “Once the patient is home, our team focuses their attention closely on the key causes of preventable readmissions. We are so happy that our efforts were so successful last year.”

Georgetown Home Care knows that in order to have a significant impact on reducing preventable readmissions and rehospitalizations the focus must be on not only the key causes, but also the understanding that as a company it plays a key role in the patient-centric care system. Home care providers have the unique position of being with a client/patient more than any other of his/her care providers. The impact can be very meaningful.

Georgetown Home Care is the premier non-medical home care agency with offices in DC, Maryland and Virginia. Its mission is to ensure a better quality of life for elderly clients and their families by providing dependable and affordable care. Georgetown Home Care is a locally-owned and operated company and is passionate about serving seniors and those in need with hourly and live-in home care services.

Georgetown Home Care is continuing efforts to lower readmissions in 2020.

Share article on social media or email:

Health: Mental Health

Spaulding Youth Center Honored with $10,000 Grant from Doug Flutie, Jr. Foundation for Autism

Leave a comment


Spaulding Youth Center provides a robust collection of services for children and youth with special needs. This grant will support this new program and help these special children develop essential skills and abilities that will transfer into their everyday lives. From L to R: Susan C. Ryan, President & CEO, and Todd Emmons, Chief Financial Officer, of Spaulding Youth Center

From L to R: Susan C. Ryan, President & CEO, and Todd Emmons, Chief Financial Officer, of Spaulding Youth Center

“The generous support of the Doug Flutie, Jr. Foundation for Autism will make a significant impact on our organization and in the lives of the children we serve, 60% or more of whom are on the Autism spectrum” said Susan C. Ryan, President & CEO of Spaulding Youth Center.


MANCHESTER, N.H. (PRWEB)

Spaulding Youth Center is thrilled to announce it has been honored with a grant of $10,000.00 from the Doug Flutie, Jr. Foundation for Autism. The grant will directly support Spaulding’s initiative to implement a physical fitness program for students with autism.

The physical fitness program will include the hiring of a fitness professional who will complete the Autism Fitness Level 1 Certification from Autism Fitness® and then work with Spaulding staff to design a ten-week, biweekly program for students ages 5 to 21. This fitness professional will also work directly with staff to develop different strategies to use with autistic students in settings outside of the fitness class.

“The generous support of the Doug Flutie, Jr. Foundation for Autism will make a significant impact on our organization and in the lives of the children we serve, 60% or more of whom are on the Autism spectrum,” said Susan C. Ryan, President & CEO of Spaulding Youth Center. “Spaulding Youth Center provides a robust collection of services for children and youth with special needs. As we continuously strive to develop new opportunities for our students, we’ve always embraced the importance of having a physical movement program designed specifically to meet the needs those diagnosed with autism. This grant will support this new program and help these special children develop essential skills and abilities that will transfer into their everyday lives.”

“The Flutie Foundation Signature Grants help our partner agencies address a variety of significant needs in the autism community,” says Nick Savarese, Executive Director of The Doug Flutie Jr. Foundation for Autism. “Programs like Spaulding Youth Center are helping people on the autism spectrum live life to the fullest and we are proud to support their efforts.”

The Doug Flutie, Jr. Foundation for Autism, based in Framingham, MA, awards grants annually through a competitive application and review process. The signature grants that the Flutie Foundation distributed this year support traditionally under-served, under-funded, culturally diverse communities reflected in the Foundation’s areas of interest; providing a path for educational and vocational skills, supporting recreational and active lifestyles, and ensuring people with autism are safe, supported and informed.

ABOUT SPAULDING YOUTH CENTER

Spaulding Youth Center is a leading provider of services for children and youth with neurological, emotional, behavioral, learning and/or developmental challenges, including Autism Spectrum Disorder and those who have experienced significant trauma, abuse or neglect. Services include academic, behavioral health, residential, foster care, health and wellness and family support. Spaulding Youth Center is a tax-exempt 501(c)(3) nonprofit. For information about Spaulding Youth Center, visit http://www.SpauldingYouthCenter.org.

ABOUT THE DOUG FLUTIE, JR. FOUNDATION FOR AUTISM

The Doug Flutie Jr. Foundation for Autism (DFJFA) is a not-for-profit 501(c)(3) public benefit corporation helping families affected by autism live life to the fullest. Through programs and partnerships, DFJF helps people with autism get access to care; lead more active lifestyles; and grow toward adult independence. NFL Quarterback Doug Flutie and his wife Laurie, whose personal experience raising a son on the autism spectrum inspired their passion to help other families, established the Foundation in 1998. DFJFA primarily serves families throughout New England, New York, New Jersey, and Central Florida. For more information on The Doug Flutie, Jr. Foundation for Autism, visit http://www.flutiefoundation.org.

Share article on social media or email:

Health

Molecular-based Cancer Diagnostic Market Reaches $1.6 Billion

Leave a comment


Kalorama Information logo


ARLINGTON, Va. (PRWEB)

Cancer diagnostics is a highly dynamic field that consists of various types of platforms. Molecular diagnostics platforms are increasingly becoming popular as they enable accurate diagnosis as well as prognosis evaluation, which are important for treatment decisions. In 2019, the market for molecular cancer diagnostics, including histology and assays, reached $1.6 billion, increasing 11.5% over roughly $1.435 billion in 2018. For 2020, growth is expected to remain relatively stable, driving the market to $1.77 billion for the year. Roche leads the market for oncology, but Illumina comes in second, a testament to the increasing use of next-generation sequencing systems (NGS). This is according to Kalorama Information’s new report, “Molecular Cancer Diagnostics“.

Rapid uptake of NGS is expected to have significant influence on cancer diagnostics and cancer management. According to the report. NGS allows comprehensive description of germ-line DNA, analysis of somatic mutations, RNA profiles of naturally occurring tumors, and more. However, clinical integration of these advancements is expected to take a while. Even the integration of straightforward assays such as for EGFR mutation or BRCA1/2 took several years, and still many related issues are being studied. Hence, clinical medicine may not immediately benefit significantly from the increasing numbers of novel candidate markers due to the long time needed for clinical validation of molecular cancer diagnostics methods. Still, the demand for single-gene genomics is expected to grow in cancer diagnostics, mainly in advanced markets such as the U.S.

Promising innovation is evident in other relatively established markets as well, such as polymerase chain reaction (PCR) and in situ hybridization (ISH). For instance, the PCR-based molecular cancer diagnostics segment is being revolutionized by high-sensitivity technologies such as emulsion PCR, including digital droplet PCR (ddPCR), and advanced separation reagents. ISH-based cancer assays are covered under the molecular histology application in the report.

There are several growth opportunities in the molecular cancer diagnostics market including the following:


  • • The global market is expected to experience a strong compound annual growth rate (CAGR) through 2025.

  • • The use of NGS technologies and liquid biopsy methods are increasing, while PCR-based testing in developed markets is decreasing.

  • • There is a growing interest in research and clinical markets for companion diagnostic tests and an increasing market growth for pharmacodiagnostics.

  • • The Asia-Pacific market will increase at high double-digit rates.

  • • Latin America continues to gain momentum but still slower than the global average.

  • • The U.S. will remain the largest market for molecular cancer diagnostics through 2025.

Kalorama’s “Molecular Cancer Diagnostics” report reviews the current makeup of the molecular diagnostics market for cancer, including its notable products and geographical segmentation. The report also reviews expected developments, such as technology and product introduction. Expectations for molecular diagnostics for cancer include the introduction of more biofluid-based (e.g., blood, urine) samples and tests indicated for cancer detection and monitoring. However, the current market remains largely composed of tissue-based tests, companion assays, and tests for the prognosis and diagnosis of specific cancer types. Some of the most significant developments in this field that may have an impact in shaping cancer diagnostics and treatment management are assessed throughout the report. The report also includes statistical information for cancers by type on a global level.

All market data pertain to the global market at the manufacturers’ level. The base year for data is 2019 with projections for 2020 and a forecasted market through 2025. Competitive analysis is provided for estimated and published data gathered for the 2019 year. The forecasted market analysis is based on product availability, cancer indications and sales of products expected to reach market by 2025, competitive trends, product marketing, cancer epidemiology, and demographic trends.

Information for this report was gathered using both primary and secondary research, including comprehensive research of secondary sources, such as company reports and literature, government documents and databases, research journals and reports, and general medical and business journals.

Primary research methods included telephone interviews and email correspondence with company representatives, researchers, government representatives, and physicians. These interviews were conducted with the purpose of capturing the perspectives from industry participants on the market opportunity and current trends. This was the basis of formulating forecast models and confirming early findings related to market potential. Secondary research included billing databases and pricing charts.

Kalorama’s report is available at: https://kaloramainformation.com/product/molecular-cancer-diagnostics-market/.

About Kalorama Information

For more than 30 years, Kalorama Information has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.

Share article on social media or email:

health and fitness

U.S.-Based Backyard Adventure Manufacturer, b4Adventure, Set to Begin Distribution of Plum Play Products

Leave a comment


News Image

“I am passionate about the need to play outside and the positive effect it has on anyone, but especially children,” said Ed O’Brien. “So when I met the team at Plum and felt that same passion and belief from them, it was clear this was going to be an ideal partnership.”


DENVER (PRWEB)

b4Adventure, an international manufacturer of backyard adventure gear and active play toys, recently partnered with UK-based Plum Play to distribute Plum Play structures and products to its large network of retail partners in the United States.

b4Adventure was founded in 2011 on the belief that outdoor play has a monumental role in the physical and mental health of young children, and they should be encouraged to not just play, but go outside and explore nature.

“I am passionate about the need to play outside and the positive effect it has on anyone, but especially children,” said Ed O’Brien, founder and owner of b4Adventure. “So when I met the team at Plum and felt that same passion and belief from them, it was clear this was going to be an ideal partnership set out to achieve the same thing – getting more kids to play outside!”

Plum Play was founded in 1988 by a husband and wife team with three children who started the company to provide kids with the tools they need to let their imaginations run wild. Plum Play now sells to more than 40 countries with a catalog of more than 150 products.

“We are always thrilled to enter a new market, but our partnership with b4Adventure is more exciting than usual because of the great synergy between our company missions,” said Philip James, Director of Sales for Plum Play.

Plum Play will be attending Toy Fair New York to support their distribution expansion into the U.S. and to debut its innovative Bowl Trampoline which will be displayed in the lobby of Javits Center throughout the show, February 22-25. To see some of the b4Adventure and Plum products, Toy Fair attendees can visit booth #5859 on the lower level.

The partnership between the two companies officially kicked off in January 2020. To learn more about the products that are now available in the U.S., you can visit plumplay.com.

About b4Adventure

b4Adventure is a manufacturer of outdoor adventure and active toys that encourage kids of all ages to get outdoors, stay active and have fun while doing it! Founded in 2011, the b4Adventure family of brands includes Slackers, American Ninja Warrior, Playzone-Fit and 4Fun, and has something to offer every level of adventurer from toddler stage all the way through to adulthood. b4Adventure operates on the belief that great things happen when kids stay active and play outdoors.

About Plum Play

Passionate about play, Plum helps to nurture curiosity and creativity by creating a safe and fun environment, allowing children the freedom to play and the parent peace of mind. With over 30 years of experience, Plum products are designed for every stage of childhood with great quality and kind to the environment. From 12 months old to teenage years and beyond, Plum will help you discover the best products for your child’s development through play, and create a childhood of great memories.

Share article on social media or email:

Industry: Healthcare

Laser Research Introduces Medical Laser Optics That are Optimized for Nd:YAG Lasers

Leave a comment


Supplied in 1/2” and 3/4” dia. sizes, Laser Research ZnSe Optics can be furnished with dual-band and reflectance coatings up to 95% on each side.

Supplied in 1/2” and 3/4” dia. sizes, ZnSe Optics can be furnished with dual-band and reflectance coatings up to 95% on each side.

These ZnSe Optics are optimized at 1064 nm for Nd:YAG medical lasers and are available as plano-convex and plane-parallel discs, output couplers, and mirrors.


PROVIDENCE, R.I. (PRWEB)

Laser Research Optics has introduced custom manufactured ZnSe optics for OEMs that are optimized at 1064 nm and are ideally suited for virtually all types of medical lasers.

Laser Research ZnSe Optics are optimized at 1064 nm for Nd:YAG medical lasers and are available as plano-convex and plane-parallel discs, output couplers, and mirrors. Suitable for virtually all types of medical lasers, they feature 40-20 scratch-dig surface finishes per MIL-O-13830 (20-10 one face on plane-parallel) and can be manufactured to OEM specifications.

Supplied in 1/2” and 3/4” dia. sizes, Laser Research ZnSe Optics can be furnished with dual-band and reflectance coatings up to 95% on each side. Flatness is held to 1/4th wave at HeNe and surface accuracy at 10.6 microns, with 3 arc-mins. maximum parallelism.

Laser Research ZnSe Optics for Nd:Yag medical lasers are priced according to configuration and quantity. Price quotations are available upon request.

For more information contact:

Laser Research Optics

A Division of Meller Optics, Inc.

Scott Rouillard, Sales Mgr.

120 Corliss St.

Providence, RI 02904

(888) 239-5545 FAX (401) 331-4004

e-mail: scott@laserresearch.net

http://www.laserresearch.net

Share article on social media or email:

Health: Mental Health

Rochester-based Nadarra Lighting, Ready to Sell Decorative OLED Light Fixtures, as a Channel Partner of OLEDWorks

Leave a comment


OLEDWorks - leading manufacturer od OLED light technology

We need to be aware of how light impacts us beyond allowing us to see, but how it impacts our emotional well-being. We design light fixtures, which utilize OLED technology, so we can be a lighting solution that not only looks good, but also makes you feel good.


ROCHESTER, N.Y. (PRWEB)

Nadarra Lighting (“Nadarra”), a start-up lighting designer and manufacturer, headquartered in Rochester, NY, has developed modern, eye-catching, decorative light fixtures, geared towards the hospitality industry, which utilize OLED light panels. Nadarra made a conscious decision to utilize OLED light panels, due to the technology’s wellness component. The formation of this new company leverages partnerships in Rochester’s backyard. Nadarra will source its OLED light panels exclusively from OLEDWorks, as a member of their Channel Partner Program. The Channel Partner Program provides early adopters expanded access to OLEDWorks’ OLED light technology, engineering mindshare, marketing and sales advocacy, and more. Nadarra is among the first companies in the United States, exclusively dedicated to manufacturing decorative light fixtures that use OLED light panels.

“Nadarra Lighting was an early adopter of OLED light and has an impressive portfolio of OLED luminaires,” says John Rubens, Vice President of Customer Success at OLEDWorks. “We’ve always believed in the potential for OLED applications in the hospitality space, and Nadarra has brought that belief to life. We’re excited to see what we can do together this year as our partnership expands, and they develop new fixtures in unique designs.”

Nadarra has designed and manufactured specification-grade, decorative OLED light fixtures, geared towards the hospitality industry, with plans to expand product and market offerings in upcoming years. The company is focused on the health and wellness of light. Nadarra believes that light needs to be understood as something that can directly impact emotional and physical well-being. With health and wellness being a main component of the hospitality and tourism market, Nadarra saw a need to develop light fixtures that could assist interior designers, architects, owner/operators, and other key hospitality personnel, to bring health and wellness to their guests, through light design. OLED technology poses no blue light risk to your eyes, and is circadian rhythm friendly, leading to better overall health and well-being. The company has future plans to target other health and wellness industries, such as senior living, and long-term care facilities.

In addition to the health and wellness of light, Nadarra is passionate about the creative freedom that OLED’s unique form factor brings to interior designers, architects and other professionals in the hospitality industry. All of Nadarra’s current OLED light fixtures are designed to behave as eye-catching focal points within a space. Nadarra believes that OLED technology, and LED technology can work well together. That the combination of the two will provide for an unforgettable end-user experience. By utilizing Nadarra’s OLED light fixtures, alongside LED ambient lighting, designers now have another tool to address issues with light, and enhance the customer/guest experience.

Bill McDonnell, founder of Nadarra Lighting is passionate about creating a commercial space for OLED light technology. Bill states, “lighting impacts us in so many ways throughout our day. We need to be aware of how light impacts us beyond allowing us to see, but how it impacts our emotional well-being. Believe it or not, lighting is very personal and needs to be viewed and applied in our life that way. We design light fixtures, which utilize OLED technology, so we can be a lighting solution that not only looks good, but also makes you feel good.”

The Formation of Nadarra comes as OLED technology continues to gain traction in the market. New research and development is allowing for continued advancement in streamlining processes and procedures, and ultimately leading to a lower price point. OLED was first invented at Kodak in 1987 by chemists Ching W. Tang and Steven Van Slyke. In recent years, OLEDWorks has been an industry leader in continued research and advancement in the OLED field. “It was an obvious choice to exclusively partner with OLEDWorks for our OLED light panels,” states McDonnell. “Not only are they the industry leader, producing the highest quality OLED light panels in the world, they are a true story of entrepreneurship and teamwork, right in Rochester.”

About Nadarra Lighting

Nadarra Lighting is headquartered in downtown Rochester, New York. The company has an in-depth focus on the health and wellness of light, selling decorative OLED light fixtures that look and feel good. Nadarra’s OLED light fixtures are geared towards the commercial industry, and more specifically the hospitality industry. Those interested in learning more about Nadarra and OLED technology can visit the company’s website at http://www.nadarralighting.com. For more information, industry updates, and advancements in OLED technology, follow Nadarra on Instagram, LinkedIn, and Twitter – @Nadarralighting.

About OLEDWorks

OLEDWorks is a global leader in the development and production of innovative organic light-emitting diode (OLED) lighting solutions. Founded in 2010 in Rochester NY by many of the original pioneers in the OLED industry, OLEDWorks creates reliable, beautiful and cost-effective OLED light engines that inspire architects, designers and manufacturers around the world.

By producing the world’s best performing OLED panels and combining rapid product innovation, OLEDWorks simplifies and enriches your illuminated space. Free from blue light hazards, OLED is the healthy and beautiful light solution. Sustainable and environmentally responsible, OLEDWorks’ OLED light engines enhance the well-being of our world and its inhabitants.

OLEDWorks invites the architectural lighting community to Experience OLED Light at Light + Building 2020 and attend a 30-minute educational sprint at LEDucation 2020 to discuss the health and well-being benefits of OLED light.

Share article on social media or email: